CXS 0.00% 70.0¢ chemgenex pharmaceuticals ltd

three big announcements, page-2

  1. 206 Posts.
    My reading of the trading is that there is one or more big holders getting out. Collier indicated that might be the case in the teleconference regarding those that took part in the placement at 43 cents per share.

    There will also be some nervousness leading up to the ODAC meeting. Over ten years ago, when Relenza went before ODAC they recommended the drug not be approved. Needless to say, Biota shares went into free fall.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.